aluates Reports

$ 0.0

Automative

Global Macular Degeneration Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-30N991

Global Macular Degeneration Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Macular Degeneration Treatment Market Research Report 2025

Code: QYRE-Auto-30N991

Report

September 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bausch Health Companies

Allergan plc

Novartis

Pfizer Inc

Bayer

Roche

Sanofi

Santen Pharmaceuticals

Regeneron Pharmaceuticals

Kanghong Pharma

Macular Degeneration Treatment Market Size

The global market for Macular Degeneration Treatment was valued at US$ 6571 million in the year 2024 and is projected to reach a revised size of US$ 8388 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Macular Degeneration Treatment Market

Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Macular Degeneration Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Degeneration Treatment.

The Macular Degeneration Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macular Degeneration Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Macular Degeneration Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Macular Degeneration Treatment Market Report

Report Metric	Details
Report Name	Macular Degeneration Treatment Market
Accounted market size in year	US$ 6571 million
Forecasted market size in 2031	US$ 8388 million
CAGR	3.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lucentis Eylea Avastin Others
Segment by Application	Hospitals Eye Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bausch Health Companies, Allergan, Novartis, Pfizer, Bayer, Roche, Sanofi, Santen Pharmaceuticals, Regeneron Pharmaceuticals, Kanghong Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Degeneration Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Macular Degeneration Treatment Market growing?

Ans: The Macular Degeneration Treatment Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Macular Degeneration Treatment Market size in 2031?

Ans: The Macular Degeneration Treatment Market size in 2031 will be US$ 8388 million.

Who are the main players in the Macular Degeneration Treatment Market report?

Ans: The main players in the Macular Degeneration Treatment Market are Bausch Health Companies, Allergan, Novartis, Pfizer, Bayer, Roche, Sanofi, Santen Pharmaceuticals, Regeneron Pharmaceuticals, Kanghong Pharma

What are the Application segmentation covered in the Macular Degeneration Treatment Market report?

Ans: The Applications covered in the Macular Degeneration Treatment Market report are Hospitals, Eye Clinics, Others

What are the Type segmentation covered in the Macular Degeneration Treatment Market report?

Ans: The Types covered in the Macular Degeneration Treatment Market report are Lucentis, Eylea, Avastin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Lucentis

1.2.3 Eylea

1.2.4 Avastin

1.2.5 Others

1.3 Market by Application

1.3.1 Global Macular Degeneration Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Eye Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Macular Degeneration Treatment Market Perspective (2020-2031)

2.2 Global Macular Degeneration Treatment Growth Trends by Region

2.2.1 Global Macular Degeneration Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Macular Degeneration Treatment Historic Market Size by Region (2020-2025)

2.2.3 Macular Degeneration Treatment Forecasted Market Size by Region (2026-2031)

2.3 Macular Degeneration Treatment Market Dynamics

2.3.1 Macular Degeneration Treatment Industry Trends

2.3.2 Macular Degeneration Treatment Market Drivers

2.3.3 Macular Degeneration Treatment Market Challenges

2.3.4 Macular Degeneration Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Macular Degeneration Treatment Players by Revenue

3.1.1 Global Top Macular Degeneration Treatment Players by Revenue (2020-2025)

3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Macular Degeneration Treatment Revenue

3.4 Global Macular Degeneration Treatment Market Concentration Ratio

3.4.1 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Macular Degeneration Treatment Revenue in 2024

3.5 Global Key Players of Macular Degeneration Treatment Head office and Area Served

3.6 Global Key Players of Macular Degeneration Treatment, Product and Application

3.7 Global Key Players of Macular Degeneration Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Macular Degeneration Treatment Breakdown Data by Type

4.1 Global Macular Degeneration Treatment Historic Market Size by Type (2020-2025)

4.2 Global Macular Degeneration Treatment Forecasted Market Size by Type (2026-2031)

5 Macular Degeneration Treatment Breakdown Data by Application

5.1 Global Macular Degeneration Treatment Historic Market Size by Application (2020-2025)

5.2 Global Macular Degeneration Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Macular Degeneration Treatment Market Size (2020-2031)

6.2 North America Macular Degeneration Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Macular Degeneration Treatment Market Size by Country (2020-2025)

6.4 North America Macular Degeneration Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Macular Degeneration Treatment Market Size (2020-2031)

7.2 Europe Macular Degeneration Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Macular Degeneration Treatment Market Size by Country (2020-2025)

7.4 Europe Macular Degeneration Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Macular Degeneration Treatment Market Size (2020-2031)

8.2 Asia-Pacific Macular Degeneration Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Macular Degeneration Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Macular Degeneration Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Macular Degeneration Treatment Market Size (2020-2031)

9.2 Latin America Macular Degeneration Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Macular Degeneration Treatment Market Size by Country (2020-2025)

9.4 Latin America Macular Degeneration Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Macular Degeneration Treatment Market Size (2020-2031)

10.2 Middle East & Africa Macular Degeneration Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Macular Degeneration Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Macular Degeneration Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bausch Health Companies

11.1.1 Bausch Health Companies Company Details

11.1.2 Bausch Health Companies Business Overview

11.1.3 Bausch Health Companies Macular Degeneration Treatment Introduction

11.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2020-2025)

11.1.5 Bausch Health Companies Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Macular Degeneration Treatment Introduction

11.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Macular Degeneration Treatment Introduction

11.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Macular Degeneration Treatment Introduction

11.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Macular Degeneration Treatment Introduction

11.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2020-2025)

11.5.5 Bayer Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Macular Degeneration Treatment Introduction

11.6.4 Roche Revenue in Macular Degeneration Treatment Business (2020-2025)

11.6.5 Roche Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Macular Degeneration Treatment Introduction

11.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Santen Pharmaceuticals

11.8.1 Santen Pharmaceuticals Company Details

11.8.2 Santen Pharmaceuticals Business Overview

11.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Introduction

11.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2020-2025)

11.8.5 Santen Pharmaceuticals Recent Development

11.9 Regeneron Pharmaceuticals

11.9.1 Regeneron Pharmaceuticals Company Details

11.9.2 Regeneron Pharmaceuticals Business Overview

11.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Introduction

11.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2020-2025)

11.9.5 Regeneron Pharmaceuticals Recent Development

11.10 Kanghong Pharma

11.10.1 Kanghong Pharma Company Details

11.10.2 Kanghong Pharma Business Overview

11.10.3 Kanghong Pharma Macular Degeneration Treatment Introduction

11.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2020-2025)

11.10.5 Kanghong Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bausch Health Companies

Allergan plc

Novartis

Pfizer Inc

Bayer

Roche

Sanofi

Santen Pharmaceuticals

Regeneron Pharmaceuticals

Kanghong Pharma

List of Tables

Table 1. Global Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Lucentis

Table 3. Key Players of Eylea

Table 4. Key Players of Avastin

Table 5. Key Players of Others

Table 6. Global Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Macular Degeneration Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Macular Degeneration Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Macular Degeneration Treatment Market Share by Region (2020-2025)

Table 10. Global Macular Degeneration Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Macular Degeneration Treatment Market Share by Region (2026-2031)

Table 12. Macular Degeneration Treatment Market Trends

Table 13. Macular Degeneration Treatment Market Drivers

Table 14. Macular Degeneration Treatment Market Challenges

Table 15. Macular Degeneration Treatment Market Restraints

Table 16. Global Macular Degeneration Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Macular Degeneration Treatment Market Share by Players (2020-2025)

Table 18. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration Treatment as of 2024)

Table 19. Ranking of Global Top Macular Degeneration Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Macular Degeneration Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Macular Degeneration Treatment, Headquarters and Area Served

Table 22. Global Key Players of Macular Degeneration Treatment, Product and Application

Table 23. Global Key Players of Macular Degeneration Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Macular Degeneration Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Macular Degeneration Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Macular Degeneration Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Macular Degeneration Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Macular Degeneration Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Macular Degeneration Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Macular Degeneration Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Macular Degeneration Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Macular Degeneration Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Macular Degeneration Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Macular Degeneration Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Macular Degeneration Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Macular Degeneration Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Macular Degeneration Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Macular Degeneration Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Macular Degeneration Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Macular Degeneration Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Macular Degeneration Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Macular Degeneration Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bausch Health Companies Company Details

Table 49. Bausch Health Companies Business Overview

Table 50. Bausch Health Companies Macular Degeneration Treatment Product

Table 51. Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 52. Bausch Health Companies Recent Development

Table 53. Allergan Company Details

Table 54. Allergan Business Overview

Table 55. Allergan Macular Degeneration Treatment Product

Table 56. Allergan Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 57. Allergan Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Macular Degeneration Treatment Product

Table 61. Novartis Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Macular Degeneration Treatment Product

Table 66. Pfizer Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 67. Pfizer Recent Development

Table 68. Bayer Company Details

Table 69. Bayer Business Overview

Table 70. Bayer Macular Degeneration Treatment Product

Table 71. Bayer Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 72. Bayer Recent Development

Table 73. Roche Company Details

Table 74. Roche Business Overview

Table 75. Roche Macular Degeneration Treatment Product

Table 76. Roche Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 77. Roche Recent Development

Table 78. Sanofi Company Details

Table 79. Sanofi Business Overview

Table 80. Sanofi Macular Degeneration Treatment Product

Table 81. Sanofi Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 82. Sanofi Recent Development

Table 83. Santen Pharmaceuticals Company Details

Table 84. Santen Pharmaceuticals Business Overview

Table 85. Santen Pharmaceuticals Macular Degeneration Treatment Product

Table 86. Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 87. Santen Pharmaceuticals Recent Development

Table 88. Regeneron Pharmaceuticals Company Details

Table 89. Regeneron Pharmaceuticals Business Overview

Table 90. Regeneron Pharmaceuticals Macular Degeneration Treatment Product

Table 91. Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 92. Regeneron Pharmaceuticals Recent Development

Table 93. Kanghong Pharma Company Details

Table 94. Kanghong Pharma Business Overview

Table 95. Kanghong Pharma Macular Degeneration Treatment Product

Table 96. Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2020-2025) & (US$ Million)

Table 97. Kanghong Pharma Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Macular Degeneration Treatment Picture

Figure 2. Global Macular Degeneration Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Macular Degeneration Treatment Market Share by Type: 2024 VS 2031

Figure 4. Lucentis Features

Figure 5. Eylea Features

Figure 6. Avastin Features

Figure 7. Others Features

Figure 8. Global Macular Degeneration Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Macular Degeneration Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Eye Clinics Case Studies

Figure 12. Others Case Studies

Figure 13. Macular Degeneration Treatment Report Years Considered

Figure 14. Global Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Macular Degeneration Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Macular Degeneration Treatment Market Share by Region: 2024 VS 2031

Figure 17. Global Macular Degeneration Treatment Market Share by Players in 2024

Figure 18. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration Treatment as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Macular Degeneration Treatment Revenue in 2024

Figure 20. North America Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Macular Degeneration Treatment Market Share by Country (2020-2031)

Figure 22. United States Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Macular Degeneration Treatment Market Share by Country (2020-2031)

Figure 26. Germany Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Macular Degeneration Treatment Market Share by Region (2020-2031)

Figure 34. China Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Macular Degeneration Treatment Market Share by Country (2020-2031)

Figure 42. Mexico Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Macular Degeneration Treatment Market Share by Country (2020-2031)

Figure 46. Turkey Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Macular Degeneration Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Bausch Health Companies Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 50. Allergan Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 53. Bayer Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 54. Roche Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 55. Sanofi Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 56. Santen Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 57. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 58. Kanghong Pharma Revenue Growth Rate in Macular Degeneration Treatment Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Macular Edema and Macular Degeneration Market Research Report 2025

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030

Geographic Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Wet Macular Degeneration Market Research Report 2024

Global Geographic Atrophy Market Research Report 2025

Global Retinal Disorders Treatment Market Research Report 2024

Global Visual Impairment Market Research Report 2024

Global Cone rod Dystrophy Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions